This is a very relevant point about the ploidy status that has been suggested.
- Read depth can be measured by what is suggested.
- If your goal is DE analysis your coverage of 32M is good enough to start with if you have already enough replicates that support your experimental design.
- Yes, I agree GATK is very much well suited for diploid genomes.
- Are you aware of the ploidy status probably this link might shed some more information? Check this biostars link and see that RNA-Seq is not the correct way for estimating the ploidy status based on
coverage.
Please reformat your question and the read stats for people to read it well so that they can help you out!
What do you mean with reliable?
Per definition, RNA-seq is not well suited for variant calling.
By reliable I want to know the quality of this data or know some way of doing it.
I have few suggestions. If you are interrogating transcriptome data via RNA-Seq then it is designed specifically to quantify transcriptomes and not genomes where you will target variants a.k.a SNPs as you are calling them.
You should better look for expression estimates and make a study of gene expression and downstream functional studies.
If you are interested in doing variant analysis then better to go for whole genome or whole exome. Depth in WGS/WES matters for the variant analysis. What have you employed for variant calling with this data, like the tools and the workflow? What parameters?
Any particular reason you want to use RNA-Seq for variant analysis and not WGS/WES?
If it's a budget constraint and you want to find both from RNA-Seq then you have to make a trade off. Your depth is not very high to fish out very reliable SNPs from your data however you can try with GATK variant calling from RNASeq. Pretty much detailed and informative and will be a good start.
Transcript depth and single nucleotide estimates are not the same. So understand that difference. If you read carefully and understand your motivation of what you want to do probably you will have better way to deal with this data.
Thanks for your suggestions
I have given a reply to the below answer, take a look there. Having said if data is not good for identifying DEGs at this stage is pretty strong apriori decision. Yes you need the ploidy status for your data if you have them with you and that can be pretty informative for designing the RNA-Seq analysis for DE analysis.
Just to make sure from the beginning, when you have the counts file from your samples and make a PCA, what do you observe? do they get distributed in space according to your condition or strong by another variability. This gives you a biological inference as well. Alternatively, perform the same with normalized expression data. Pretty amazing workflows are suggested by limma, edgeR and DESeq2.
There is a crude approach to still get it done but not very accurate but gives you a flavor of ploidy status based on read coverage. Check this. Good luck
I've not created counts table yet. Will do PCA afterward and see. Also, thank you for this link, its a really interesting point I learned from this discussion.